60 studies found for:    Open Studies | "heart transplantation"
Show Display Options
Rank Status Study
21 Recruiting Physiologic Assessment of Microvascular Function in Heart Transplant Patients
Condition: Cardiac Allograft Vasculopathy
Intervention:
22 Recruiting Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients
Conditions: Coronary Disease;   Heart Transplant
Intervention: Biological: Mesenchymal cell therapy
23 Recruiting Remote Ischemic Preconditioning With Postconditioning in Heart Transplantation Surgery
Conditions: Myocardial Ischemic Reperfusion Injury;   End Stage Heart Disease;   Heart Failure;   Cardiomyopathy
Interventions: Procedure: RIPC+RIPostC;   Procedure: control
24 Recruiting Impact of Stress Management Training After Cardiac Transplantation
Condition: Heart Transplant
Intervention: Behavioral: Stress management
25 Recruiting Multi-Drug Desensitization Protocol for Heart Transplant Candidates
Condition: Heart Transplantation
Intervention: Drug: Bortezomib, Thymoglobulin, (rATG), Rituximab, Gamimune N, (IVIG), Plasmapheresis (Multidrug Protocol)
26 Recruiting Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2
Conditions: Acute Graft Rejection;   Heart Transplantation
Intervention: Device: MRI T2 quantification
27 Unknown  Fish Oil In Heart Transplantation
Condition: Myocardial Tissue in Heart Transplantation
Intervention: Dietary Supplement: Fish Oil
28 Recruiting Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
Conditions: Heart Failure;   Cardiac Failure;   Congestive Heart Failure;   Heart Failure, Left-sided
Interventions: Device: HeartAssist 5® VAD System;   Device: Control VAD
29 Not yet recruiting FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC
Condition: Systemic Sclerosis
Intervention:
30 Recruiting On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients
Conditions: Vascular; Change;   Dietary Modification;   Physical Activity;   Health Behavior;   Attitude to Health
Intervention: Other: On-Line Diet and Exercise Intervention
31 Unknown  Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
Conditions: Heart Transplantation;   Cardiac Allograft Vasculopathy;   Cytomegalovirus Infection
Interventions: Drug: Pre-emptive strategy with valganciclovir plus everolimus;   Drug: Prophylaxis with valganciclovir plus mycophenolate;   Drug: Prophylaxis with valganciclovir plus everolimus;   Drug: Pre-emptive mycophenolate
32 Unknown  Medication Adherence Enhancement in Heart Transplant Recipients
Conditions: Medication Adherence;   Self Management;   Rejection
Intervention: Behavioral: behavioral adaptation and symptom management
33 Recruiting Study of Heart Transplant Rejection
Condition: Heart Transplantation
Intervention:
34 Recruiting Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
Condition: End Stage Heart Disease
Intervention: Device: Early VAD implantation
35 Unknown  Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
Condition: Heart Transplantation
Intervention: Drug: Bradykinin
36 Unknown  A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Thymoglobulin
37 Unknown  Cardiac Allograft Remodeling and Effects of Sirolimus
Conditions: Cardiac Hypertrophy;   Immunosuppression
Interventions: Radiation: Cardiac MRI;   Procedure: Coronary angiography with IVUS;   Other: Cardiac Allograft Remodeling;   Drug: M-TOR Immunosuppression;   Procedure: Cardiac Biopsy C4D stain;   Genetic: Genetic Mechanism of M-TOR;   Other: Cardiopulmonary Exercise Test (CPET)
38 Recruiting Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
39 Recruiting Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Condition: Congestive Heart Failure
Intervention:
40 Recruiting COVADIS Pilot Trial: COseal in Ventricular Assist DevIceS
Condition: End-stage Heart Failure Awaiting VAD Implantation
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years